• Home
  • Serum Institute of India

Serum Institute seeks DCGI nod for Covid vaccine Covovax

Serum Institute of India to supply nearly 22 cr doses of Covishield vaccine to Centre in Oct

Had to fall at bureaucrats’ feet 50 years ago, but red-tape, licence raj came down under Modi govt: Poonawalla

Decision on emergency use listing of Covaxin likely in 4-6 weeks, says WHO

WHO working with AstraZeneca, SII, Indian govt to restart vax shipment

Serum Institute of India applies to DCGI to manufacture Covid vaccine Sputnik V

Modi-Johnson virtual summit brings deals worth £1 bn, Enhanced Trade Partnership

Serum Institute defends vaccine pricing, says initial rates based on advance funding

Serum prices COVID vaccine for pvt hospitals at Rs 600/dose; for state govts at Rs 400/dose

SII CEO urges US to lift raw material export ban to ramp up vaccine production

7 blood clot deaths after 18.1 mn jabs, AstraZeneca vaccine safe, states UK regulator

Oxford-AstraZeneca jabs effective against severe COVID-19, new trial in US confirms

Nepal gives emergency use approval to Bharat Biotech’s Covaxin

Serum Institute seeks govt’s intervention over import of COVID vaccine raw material from US

Ghana is first nation in world to receive COVAX vaccines

18-19 anti-COVID-19 vaccines in pipeline says Health Min Vardhan

South Africa suspends AstraZeneca vaccine drive

25 countries in queue for “Made In India” COVID-19 vaccine says EAM

Second dose of anti-COVID-19 vaccine to be administered to healthcare workers from Feb 13

Airlifted COVID vaccines to 9 countries, will gradually supply to WHO’s COVAX facility informs India at UN

COVID-19 vaccines sent by India reach Bhutan and Maldives

Nepal approves AstraZeneca’s India-made COVID-19 vaccine for emergency use

Experts’ group slam critics of India’s COVID-19 vaccines approval process

Covishield dispatch for vaccine drive a historic moment: SII 

First flight with COVID-19 vaccines lands in Delhi from Pune

1st consignment of Covishield vaccines leaves Serum Institute

COVID-19 vaccine to cost $3-4 to govt, $6-8 in pvt mkt says Serum Institute

‘Covishield’ ready to roll out in coming weeks: Poonawalla

Free COVID-19 vaccine for all in Kerala: CM Vijayan

Country’s first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBT

Will take COVID-19 vaccine; safety, efficacy not a concern: Kiran Mazumdar-Shaw

Bharat Biotech seeks emergency use authorisation for indigenously developed COVID-19 vaccine Covaxin

Serum Institute seeks emergency use authorisation for Covishield vaccine in India

Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

Latest Additions

Pankaj survives; Amee, Ishika sail into second round

HAL to manufacture first four LUHs by 2022-23: Govt

Medical officer sexual harassment case: Dr Ratnakar granted bail

Salman Khan visits Sabarmati Ashram, tries his hands on ‘charkha’

Police have obligation to act with empathy: Kerala HC

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.